| Literature DB >> 32462990 |
Francisco Leonardo Galastri1, Leonardo Guedes Moreira Valle1, Breno Boueri Affonso1, Marcela Juliano Silva1, Rodrigo Gobbo Garcia1, Milton Rodrigues Junior2, Leonardo Jose Rolim Ferraz3, Gustavo Faissol Janot de Matos3, Farah Christina de la Cruz Scarin3, Felipe Nasser1.
Abstract
COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.Entities:
Keywords: COVID-19; anticoagulants; mechanical thrombolysis; pulmonary embolism; thrombectomy
Mesh：
Substances：
Year: 2020 PMID： 32462990 DOI： 10.1024/0301-1526/a000880
Source DB: PubMed Journal: Vasa ISSN： 0301-1526 Impact factor: 1.961